Yingjian N. He
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Protocol and statistical designs in classic clinical research-toripalimab series trial analysis.
Journal: Cancer biology & medicine
Published: April 13, 2026
Combined Pathological Response and PEPI Score Improves Long-term Prognostic Stratification in HR-positive Breast Cancer Following Neoadjuvant Endocrine Therapy.
Journal: In vivo (Athens, Greece)
Published: April 08, 2026
Efficacy of scalp cooling system versus chemical cooling cap in preventing chemotherapy-induced alopecia in breast cancer (COHAIR Study): a prospective randomized trial.
Journal: Breast (Edinburgh, Scotland)
Published: December 29, 2025
Establishment of prediction model for breast lesion using automated breast ultrasound system.
Journal: Quantitative imaging in medicine and surgery
Published: May 07, 2025
A Non-Inferior Randomized Trial of Neoadjuvant Endocrine Therapy Compared to Neoadjuvant Chemotherapy in Premenopausal Patients With Hormone-Responsive and HER2-Negative Lymph Node-Negative Breast Cancer.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: May 07, 2025
Should Sonographic Abnormal Axillary Lymph Nodes Be Excised in Sentinel Node Biopsy of Breast Cancer?
Journal: Breast care (Basel, Switzerland)
Published: April 08, 2025
Comparison of 10-Year Survival Between Patients With Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy and Patients With Initially Negative Nodes in Breast Cancer.
Journal: Clinical breast cancer
Published: November 18, 2024
ASO Author Reflections: Reflections on the Role of the Systemic Immune-Inflammation Index in Prognostic Assessment in HER2-Positive Metastatic Breast Cancer.
Journal: Annals of surgical oncology
Published: November 15, 2024
Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trial.
Journal: Signal transduction and targeted therapy
Published: September 20, 2024
Effect of Adding Electroacupuncture to Standard Triple Antiemetic Therapy on Chemotherapy-Induced Nausea and Vomiting: A Randomized Controlled Clinical Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 06, 2024
Intensive treatment of triple negative breast cancer with residual positive axillary lymph node after neoadjuvant chemotherapy.
Journal: BMC women's health
Published: August 21, 2024
Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials.
Journal: Annals of surgical oncology
Published: July 24, 2024
Last Updated: 09/26/2026